This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine's Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
Australian billionaire’s €70m superyacht spotted off Mellieħa
VOLPINI 2 is owned by Australian logistics billionaire Lindsay Fox.
MTA CEO: Richard E. Grant show can help Malta attract quality-conscious tourists
The Maltese Islands were the centre of the first episode of Richard E. Grant’s Very Modern Odyssey.
Malta’s jewellers are seeing a revival of ancient-inspired jewellery
From Roman and Greek motifs to traditional Maltese designs, local jewellers are seeing growing demand for pieces that offer history, ...
‘Europe must introduce island mechanism that protects strategic freight routes’ – JetFreight CEO
'Malta’s connection to mainland Europe is not a luxury, it is our economic lifeline,' he said.
